Advanced in Prader-Willi Syndrome

Dong-kyu K. Jin

Seoul, KR 
Advanced in Prader-Willi Syndrome
Seoul, KR 
OverviewLocationsClinical Research

Overview

Dong-kyu Jin practices in Seoul, Republic of Korea. Jin is rated as an Advanced expert by MediFind in the treatment of Prader-Willi Syndrome. Their top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Idiopathic Short Stature (ISS), Mucopolysaccharidoses (MPS), and Short Stature (Growth Disorders).

Their clinical research consists of co-authoring 128 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 12 articles in the study of Prader-Willi Syndrome.

Locations

Seoul, Republic of Korea
Other Locations
Suwon, Republic of Korea
Cheonan, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

An Open-Label, Phase 1 and Extension Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ Who Have Central Nervous System Involvement and Are Receiving Treatment with Intravenous Drug
An Open-Label, Phase 1 and Extension Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ Who Have Central Nervous System Involvement and Are Receiving Treatment with Intravenous Drug
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2024
Intervention Type: Biological
Study Phase: Phase 1

128 Total Publications

Efficacy and safety of idursulfase beta in the treatment of mucopolysaccharidosis II: A phase-3, 2-part study compared with a historical placebo cohort.
Efficacy and safety of idursulfase beta in the treatment of mucopolysaccharidosis II: A phase-3, 2-part study compared with a historical placebo cohort.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: October 22, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Jin's expertise for a condition
ConditionClose
    View All 23 Advanced Conditions
    View All 81 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile